KRAS and cancer: In turn, the target downregulated DEMs/DEPs in RRC1 were enriched in cell metabolism processes, such as the cell cycle, apoptosis, and functioning of the stomach, as well as important pathways related to cancer, such as KRAS, PI3K/AKT/mTOr, and p53 signaling (Figure 4C).